Do some beauty products pose a risk factor for #endometrialcancer ? Expert Dr. Charlotte Gamble from MedStar Health discusses studies that investigated endometrial cancer risk and beauty products. ow.ly/fVTl50RH7Bp #gyncsm

In this podcast, Omar Nadeem of @danafarber discusses the latest updates in #myeloma research, the role of emerging therapies, and advice for accessing quality myeloma care. ow.ly/AVxn50RH7aj #mmsm

What factors help determine the best approach for YOUR advanced non-melanoma #skincancer ? Register for our webinar on May 28 w/ Dr. Soo Park from UC San Diego Health Moores Cancer Center to learn more. ow.ly/xwUj50RxXqx #ANMSC

Reserve your virtual seat for the CURE Today Educated Patient® Multiple Myeloma Summit on June 8! Gain the opportunity to learn from expert physicians and network online with other patients and survivors. ow.ly/uLRq50RnjzJ #educatedpatient #multiplemyeloma

What is personalized medicine, and how can #myeloma patients access this type of care? Omar Nadeem of @danafarber shares expert insight. ow.ly/KSRw50RFJSB #bloodcancer #MMsm

Why should #gynecologiccancer patients seek a specialist? Dr. Charlotte Gamble Charlotte Gamble MD MPH from MedStar Health explains the reasoning of seeing a specialist and why a specialist may not be seen. ow.ly/y1Lr50RFIE1 #gyncsm

What are #headandneckcancer treatment approaches? Ezra Cohen shares an overview. ow.ly/PfvL50RFHVQ #hncsm

Craving for some sweet and salty snacks with a mild kick during the day? Try these maple cayenne pecans from our partner @Savor_Health!
Recipe: ina.expert/3qyKrAh

Register for Ina® for more recipes for managing side effects of cancer treatment ow.ly/3KTu50RATS4

What’s the latest in #prostatecancer clinical trials? Dr. Ronald Chen from @KUCancerCenter shares research updates and patient advice for clinical trial access. ow.ly/JkLf50RErnp #pcsm

How can #myeloma progression and bispecific antibodies be targeted? C. Ola Landgren, M.D. of Sylvester Comprehensive Cancer Center shares how progression and bispecific antibodies can be used. ow.ly/86SE50REr13 #mmsm #bloodcancer #Bispecifics

What are the next generation #myeloma treatments? Krina Patel of MD Anderson Cancer Center shares expert perspective. ow.ly/394l50REqF5 #mmsm #bloodcancer #CART #Bispecifics

Cancer survivors should thrive after treatment. Researchers at UVA are conducting a study to help cancer survivors living in or near rural Appalachia improve their quality of life. Learn More: email - [email protected], or click here: ow.ly/5LxE50RC3NS

What does research show about #prostatecancer and health equity? Dr. Ronald Chen from KU Cancer Center discusses advanced prostate cancer research findings, the INNOVATE trial, and advanced prostate cancer disparities. ow.ly/S2hl50RAkA9 #pcsm

What are #AML clinical trial disparities? Dr. Sara Taveras Alam from UTHealth Houston discusses patient factors that impact access, underrepresented patient groups, and advice for improving clinical trial access. ow.ly/3QW650RAkl6 #leusm #AML sm

What #AI advancements have emerged for #myeloma ? C. Ola Landgren, M.D. of Sylvester Comprehensive Cancer Center discusses the IRMMa prediction model and potential AI advancements for myeloma.
ow.ly/aagF50RAk6X

@Power4Patients Sr. Director of Programs Aicha Diallo & CEO @TracyRode proudly representing on day two of the National Health Council Science of Patient Engagement Symposium at the National Press Club. We even got to say hi to our Board Member, Eric Vicks.
#SPES2024 #PuttingPatientsFirst

What’s should #endometrialcancer patients to know about clinical trials? Dr. Charlotte Gamble MD MPH
from MedStar Health shares her perspective and patient advice. ow.ly/56oB50Rzr6y #gyncsm

Senior Director of Programs Aicha Diallo and CEO Tracy Rode proudly represent @Power4Patients at the National Health Council Science of Patient Engagement Symposium, 'Patient Experiences Through their Lifespan' at the National Press Club. If you are attending, come say hi!

What new #myeloma therapies are showing promise in research? Omar Nadeem of @danafarber shares an update. ow.ly/TGnR50RzqRV #bloodcancer #MMsm #CELMoDs

How can innovation lead to #headandneckcancer care improvements? Ezra Cohen from Tempus explains the positive impact of advances in technology. ow.ly/rf7v50Rzqsj #hncsm